PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10930483

Laparoscopic versus open appendectomy.

A M Merhoff·G C Merhoff·M E Franklin
View original source ↗Export metadata ↓

Abstract

BACKGROUND: Laparoscopic appendectomy is commonly performed and has been presumed to offer economic benefits similar to those of laparoscopic cholecystectomy. This study was done to examine that premise. METHODS: Two surgical groups contributed consecutively operated patients with a clinical diagnosis of appendicitis. One group did all appendectomies open and the other group did them laparoscopically. Hospital expenses were compared using a single billing formula. Hospital length of stay, time to return to work, and complications were analyzed. RESULTS: Operating room times were longer for the laparoscopic group, median 80 minutes, versus median 50 minutes for the open group. Hospital length of stay and return to work were the same, median 1 day and median 10 days, respectively. Wound complications were less common in the laparoscopic group, 0 of 30, than in the open group, 3 of 18; however, there was 1 intra-abdominal abscess in the laparoscopic group. Median cost of the laparoscopic group was $2,915 versus $1,747 for the open group. CONCLUSIONS: Laparoscopic appendectomy is more expensive than appendectomy but does not reduce hospital length of stay nor change the time to return to work; however, wound complications are less common.

Explore related subjects

AbsenteeismAcute DiseaseAdolescentAdultAgedAppendectomyAppendicitisChildCost-Benefit AnalysisFemaleHospital ChargesHospital CostsHumansLaparoscopyLength of StayMaleMiddle AgedRetrospective StudiesTechnology Assessment, BiomedicalTime FactorsWound InfectionComparative StudyJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A M Merhoff, G C Merhoff, M E Franklin. 2000. Laparoscopic versus open appendectomy.. https://doi.org/10.1016/s0002-9610(00)00373-1

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

Previous history of LBP with work loss is related to lingering deficits in biomechanical, physiological, personal, psychosocial and motor control characteristics.

A cross-sectional retrospective study was made of currently asymptomatic workers who perform physically demanding jobs. To further quantify the association between various biomechanical, physiological, personal psychosocial and motor control parameters that linger due to a history of low back disorders. Seventy-two workers were recruited from heavy industry, 26 of whom had a history of disabling low back disorders (LBDs) sufficient to miss work while the others did not. The strength of the study lies in the many detailed variables measured. Having a history of low back disorders was found to be associated with a larger waist girth, a greater potential for low back pain chronicity as predicted from psychosocial questionnaires, perturbed flexion to extension strength and endurance ratios, and widespread motor control deficits across a variety of tasks, some of which resulted in high back loads. In those workers who had missed work due to back disorders, the length of time since their last disabling episode was 261 weeks on average, suggesting that multiple deficits may remain for a period of time. Having a history of LBD is associated with changes in attitudes, in body composition, and in the way people move, load their backs and respond to a variety of motor and stability challenges.

Absenteeism↗
PubMed2003

Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine.

INTRODUCTION: Trivalent, intranasal, live attenuated influenza virus vaccine (LAIV) is safe and clinically effective in healthy, working adults. However, the potential economic benefits of vaccinating this population are still uncertain. We therefore conducted a cost benefit analysis of influenza vaccination of healthy working adults utilizing clinical outcome data from a trial of LAIV in healthy working adults. METHODS: This cost benefit analysis was based on the results of a multi-center, randomized, double blind placebo controlled trial that assessed the clinical effectiveness of LAIV in healthy working adults. Outcomes from the trial that were included in the cost benefit analysis were days of work missed, days working but at reduced effectiveness, and days with a health care provider visit due to at least one of the following symptoms: fever, runny nose, sore throat, cough, headache, muscle aches, chills, or tiredness/weakness. Cost data were obtained from nationally representative databases. Probability distributions for the key model variables were defined, and Monte Carlo simulation was used to estimate the mean break even costs for vaccine and its administration. Sensitivity analyses explored how changes in the variables affected these estimates. RESULTS: There were 4561 participants in the clinical trial. LAIV lowered work loss due to illness symptoms by 18% (relative rate [RR] 0.82, 95% confidence interval [CI] 0.74-0.91), days of working at reduced effectiveness by 18% (RR 0.82, 95% CI 0.74-0.91), and days with a health care provider visit by 13% (RR 0.87, 95% CI 0.77-0.98). The mean break even cost for vaccine and its administration was 43.07 US dollars per person vaccinated (5-95% percentiles, 25.72-58.92 US dollars). Major cost drivers were hourly wage and vaccine effectiveness in reducing productivity losses and health care use. CONCLUSION: This cost benefit analysis based on the results of the LAIV trial provides additional evidence that influenza vaccination may provide both health and economic benefits for healthy, working adults.

Absenteeism↗
PubMed2003

Environmental tobacco smoke and absenteeism related to respiratory illness in schoolchildren.

Household environmental tobacco smoke (ETS) exposure accounts for substantial morbidity among young children, but the ETS-associated morbidity burden among school-age children is less well defined. Illness-related school absenteeism is a measure of a broad spectrum of adverse effects of ETS exposure in school-age children. The authors investigated the relations between ETS exposure, asthma status, and illness-related school absenteeism in a cohort of 1,932 fourth-grade schoolchildren from 12 southern California communities during January-June 1996. Incidence rates and adjusted relative risks of illness-related absences were determined by using an active surveillance system. The effects of ETS exposure on absenteeism were assessed by using stratified incidence rates and Poisson regression to adjust for sociodemographic factors. ETS exposure was associated with an increased risk of respiratory-illness-related school absences (relative risk (RR) = 1.27, 95% confidence interval (CI): 1.04, 1.56). Children living in a household with two or more smokers were at increased risk of such absences (RR = 1.75, 95% CI: 1.33, 2.30). Children's asthma status affected their response to ETS. Compared with unexposed children without asthma, children with asthma were at increased risk of respiratory-illness-related school absences when exposed to one (RR = 2.35, 95% CI: 1.49, 3.71) or two or more (RR = 4.45, 95% CI: 2.80, 7.07) household smokers. Children without asthma also had an increased risk if exposed to two or more smokers (RR = 1.44, 95% CI: 1.04, 2.00). Therefore, ETS exposure is associated with increased respiratory-related school absenteeism among children, especially those with asthma.

Absenteeism↗